Product Images Sodium Phenylacetate And Sodium Benzoate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Sodium Phenylacetate And Sodium Benzoate NDC 68475-001 by Navinta Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
2ff6227b 08a2 471e 8b3c b1ec47b43248 01
This text appears to be a list of chemical compounds, specifically Sodium Phenylacetate and Sodium Benzoate. It is not clear what the context or usage of these compounds might be.*
2ff6227b 08a2 471e 8b3c b1ec47b43248 02
2ff6227b 08a2 471e 8b3c b1ec47b43248 03
2ff6227b 08a2 471e 8b3c b1ec47b43248 04
This is a description of Sodium Phenylacetate and Sodium Benzoate Injection, a 10% / 10% solution for intravenous use only. The injection should be administered through a central line and must be diluted with sterile, dextrose injection, 10% (D10W) before use. Each 50mL vial contains 100mg of sodium phenylacetate and 100mg of sodium benzoate. Sodium hydroxide and/or hydrochloric acid may have been used for pH adjustment. The injection is sterile, non-pyrogenic, and is a single-dose vial. The manufacturer is Navinta LLC, located in Ewing, NJ. Storage instructions recommend keeping the product between 15°-30°C (59°-86°F) and it should be kept out of reach of children. The dosage should be determined after consulting the accompanying package insert. The text contains a lot of unreadable characters indicating errors.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.